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Abstract
Background: Chronic low back pain (LBP) is the most common cause of disability worldwide. New ideas
surrounding LBP are emerging that are based on interactions between mechanical, biological and chemical
influences on the human IVD. The degenerate IVD is proposed to be innervated by sensory nerve fibres and
vascularised by blood vessels, and it is speculated to contribute to pain sensation. However, the incidence of nerve
and blood vessel ingrowth, as well as whether these features are always associated, is unknown. We investigated
the presence of nerves and blood vessels in the nucleus pulposus (NP) of the IVD in a large population of human
discs.
Methods: Immunohistochemistry was performed with 61 human IVD samples, to identify and localise nerves
(neurofilament 200 [NF200]/protein gene product 9.5) and blood vessels (CD31) within different regions of the IVD.
Results: Immunopositivity for NF200 was identified within all regions of the IVD within post-mortem tissues. Nerves
were seen to protrude across lamellar ridges and through matrix towards NP cells. Nerves were identified deep
within the NP and were in many cases, but not always, seen in close proximity to fissures or in areas where
decreased matrix was seen. Fifteen percent of samples were degenerate and negative for nerves and blood vessels,
whilst 16 % of all samples were degenerate with nerves and blood vessels. We identified 52 % of samples that were
degenerate with nerves but no blood vessels. Interestingly, only 4 % ofall samples were degenerate with no nerves
but positive for blood vessels. Of the 85 samples investigated, only 6 % of samples were non-degenerate without
nerves and blood vessels and 7 % had nerves but no blood vessels.
Conclusions: This study addresses the controversial topic of nerve and blood vessel ingrowth into the IVD in a
large number of human samples. Our findings demonstrate that nerves are present within a large proportion of NP
samples from degenerate IVDs. This study shows a possible link between nerve ingrowth and degeneration of the
IVD and suggests that nerves can migrate in the absence of blood vessels.
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Background
Chronic low back pain (LBP) is the most common cause
of disability worldwide [1], affecting 80 % of the popula-
tion at some point during life. It is estimated that 40 %
of these cases are attributable to intervertebral disc
(IVD) degeneration [2]. New ideas surrounding LBP are
slowly emerging that are based on studies demonstrating
interactions between mechanical, biological and chem-
ical influences on the human IVD.
LBP can be classified as specific or non-specific. Specific
back pain can be induced by trauma, spinal tumours or
infection. However, non-specific back pain, where the root
cause is unidentifiable, occurs in 80–90 % of LBP cases
[3]. Studies using animal models to identify the innerv-
ation patterns of the lumbar discs have revealed that the
dorsal portion of L5-S1 is innervated by the dorsal root
ganglion (DRG) from L2 by the paravertebral trunk,
whereas L3-L5 DRG innervate through the sinuvertebral
nerve, hence these patients feel non-specific pain [4, 5].
The IVD is considered the largest aneural structure
within the human body and is composed of three main
anatomical regions: the central nucleus pulposus (NP),
which is constrained by the annulus fibrosus (AF) and
the cartilaginous endplate (CEP). The IVD is a poorly
innervated organ, with sensory and sympathetic perivas-
cular nerve fibres penetrating approximately 3 mm into
the outer three lamellae of the AF [6–8]. Nerve fibres
seen within the normal IVD are typically very fine in
diameter, suggesting that they are C-fibres [9], which
typically contain neurotransmitters. Substance P and
calcitonin gene-related protein (CGRP) are known to be
involved in nociception.
Although back pain is strongly associated with nerve
root compression due to impingement of lumbar IVDs,
chronic LBP is suggested to be exacerbated by the in-
growth of these peptides containing sensory nerve fibres
into the deeper layers of the lumbar IVD. How these
nerves are able to enter the usually aneural tissue is yet
to be fully elucidated. Recent studies have demonstrated
the ability of NP cells to increase their expression of
neurotrophins and angiogenic factors in response to
various factors, such as mechanical injury [10, 11], strain
[11] and pro-inflammatory cytokines [12–16]. The ex-
pression of such molecules is suggested to potentiate the
survival and migration of nerve and blood vessels into
the degenerate IVD. In the healthy adult IVD, a number
of repulsive factors exist which prevent nerve and endo-
thelial cell ingrowth: aggrecan [17, 18]; chondromodulin
[19] and, more recently, the semaphorins [20]. However,
as expected, during degeneration these factors are re-
duced, allowing unrestricted access to the IVD.
In 1997, Freemont and colleagues used immunohisto-
chemistry to investigate the localisation of nerve and
blood vessels within the deeper layers of the IVD and
documented that these nerves contained sensory pep-
tides [21]. This study was followed up by many groups
hoping to identify a route in which these nerves and
blood vessels enter the IVD. Many have come to the
consensus that annular tears or fissures may provide a
source of entry. Stefanakis et al. showed prominence in
nerve and blood vessel localisation to fissures. They
demonstrated that these fissures have a lowered fluidic
pressure, thus making them favourable for the growth
and survival of nerves and blood vessels because in the
healthy IVD the swelling pressure exhibited by the NP
causes the collapse of such cells and prevents the occur-
rence of blood vessels [22].
The mechanisms which promote neoinnervation and
neovascularisation are yet to be fully understood and are
a topic of interest in association with their role in pain
generation. The aim of this study was to identify and
localise nerve and blood vessels within human IVD tis-
sue obtained from surgery and post-mortem (PM) to test
the hypothesis that nerve and blood vessels are present
within the deeper layers of the degenerate human IVD.
Material and methods
Human tissue
Human IVD tissue was obtained from discectomy surgery
for nerve root compression or from PM examination
(processed within 72 h after death) with informed consent
of the patient or the patient’s relatives. Ethical approval
was obtained from Sheffield Research Ethics Committee
(09/H1308/70) for 61 surgical IVD samples from 61 indi-
viduals, for 4 PM samples from 2 individuals, and for
20 PM samples from the Department of Pathology of the
University Medical Centre (UMC), Utrecht Biobank,
UMC Utrecht, used in line with the code of proper sec-
ondary use of human tissue (Table 1). Surgical samples
were classified as intact or non-intact at surgery. Intact
samples were obtained from discs where the AF remained
intact (i.e., discs remained contained), whilst in non-intact
samples the AF was ruptured and NP material was either
extruded or sequestered.
Tissue processing
Tissue processed at Sheffield Hallam University consisting
of AF and NP was fixed in 10 % neutral buffered formalin
and processed to paraffin wax. Tissue processed at Utrecht
was obtained 24 h after patient death, and IVD slices were
decalcified in Kristensen’s solution (50 % formic acid and
68 g/L sodium formate) in a microwave oven at 150 W and
50 °C for 6 h as previously described [23, 24]. Sections were
dehydrated and rinsed in xylene before being embedded in
paraffin wax. Following embedding, 4-μm sections were
received from Utrecht University, and 10-μm sections of
the surgical samples were cut and histologically graded
using previously published criteria [13, 25]. Briefly, sections
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were scored numerically between 0 and 12 on the basis of
presence of cell clusters, fissures, loss of demarcation and
haematoxophilia (indicating reduced proteoglycan content).
A score of 0–3 indicates a histologically normal (non-
degenerate) IVD, and a grade ≥4 indicates evidence of
degeneration.
Immunohistochemistry
Immunohistochemistry was used to investigate and identify
neurofilament 200 (NF200, a nerve marker), protein gene
product 9.5 (PGP9.5, a nerve marker) and cluster of
differentiation factor 31 (CD31, a blood vessel marker)
immunopositivity within rat spinal cord as a positive con-
trol obtained from Charles River Laboratories (Harlow,
UK), as well as human IVD tissues, as previously described
[26]. To visualise the morphology and staining patterns of
nerves stained with either NF200 or PGP9.5, different
thicknesses of rat spinal cord were sectioned, which en-
abled the selection of optimal tissue thickness to take for-
ward for human IVD samples. Briefly, 4-, 10- or 20-μm
sections of rat spinal cord tissue or 4- or 10-μm sections of
IVD samples were dewaxed, rehydrated and blocked with
endogenous peroxidase. Antigen retrieval methods were
used (Table 2). Following Tris-buffered saline (TBS)
washes, non-specific binding sites were blocked at room
temperature for 2 h with either 25 % wt/vol goat or rabbit
serum (Abcam, Cambridge, UK) in 1 % wt/vol bovine
serum albumin (BSA; Sigma-Aldrich, Poole, UK) in TBS
(Table 2). Sections were incubated overnight at 4 °C with
either mouse or rabbit polyclonal antibodies (Table 2).
Negative controls in which rabbit and mouse immuno-
globulin G (Abcam) replaced the primary antibody at an
equal protein concentration were used. Slides were washed
in TBS, and a 1:500 dilution of 1 % wt/vol BSA/TBS bio-
tinylated secondary antibody was applied for 30 min at
room temperature (Table 1). Binding of the secondary
antibody was detected using a streptavidin–biotin complex
(Vector Laboratories, Peterborough, UK) technique with
0.08 % vol/vol hydrogen peroxide in 0.65 mg/ml 3,3′-di-
aminobenzidine tetrahydrochloride (Sigma-Aldrich) in
TBS. Sections were counterstained with Mayer’s haema-
toxylin (Leica Microsystems, Newcastle upon Tyne, UK),
dehydrated, cleared and mounted with Pertex mounting
medium (Leica Microsystems).
All slides were visualised using a BX60 microscope
(Olympus, Southend-on-Sea, UK), and images were cap-
tured using a digital camera and QCapture Pro v8.0 soft-
ware (MediaCybernetics, Marlow, UK). Tissue samples
were investigated for expression of NF200-immunopositive
nerve cells and CD31-immunopositive blood vessels within
the NP and inner annulus fibrosus (IAF) (where present).
Within PM tissues where outer AF and CEP were present,
nerves and blood vessels in these normal locations were
not recorded as abnormal nerve and blood vessel presence.
Statistical analysis
Firstly, a χ2 test and Fisher’s exact test were used to
identify any differences between degenerate and non-
degenerate samples with or without nerves and blood
vessels. Following this step, a test of two independent
proportions was used to identify significance between
the degenerate and non-degenerate groups. Paired pro-
portion tests were used to identify differences between
proportions of nerve and blood vessels within the non-
degenerate and degenerate groups.
Results
Rat spinal cord optimisation of two nerve markers
Rat spinal cord was commercially obtained to optimise
the staining techniques and determine the ideal tissue
thickness to positively identify NF200- and PGP9.5-posi-
tive staining patterns. Varying thicknesses of tissue were
sectioned, and different staining patterns were observed
for NF200 and PGP9.5 (Fig. 1). Staining of tissues at a
thickness of 4 μm for NF200 was very clear within the
cell body, but axonal staining was lost due to the thick-
ness (Fig. 1). PGP9.5 was unclear at 4 μm. Tissues sec-
tioned at 20 μm and stained with NF200 demonstrated
filamentous staining tracking along the matrix (Fig. 1).
Staining patterns observed for PGP9.5 immunopositivity at
20-μm thickness were localised to the cell body, but this
staining was not as obvious as the staining on a 10-μm
section (Fig. 1). On the basis of this result, it was concluded
that 10-μm sections would be taken forward for IVD visual-
isation of nerve and blood vessels within human surgical
samples.
Identification of nerve and blood vessels in human IVD
tissues
Immunopositivity for NF200 was identified within the
outer annulus fibrosus (OAF), IAF and NP of IVDs with
varying grades of degeneration (Fig. 2a). In many cases,
immunopositive nervous tissue followed the tracks of the
IVD lamella (Fig. 2b) or fissures (Fig. 2c), but in some
cases nerves were seen to protrude across the lamellar
ridges or extracellular matrix (Fig. 2a) within the NP to-
wards NP cells.
Nerves were identified deep within the NP of PM and
surgical samples and were in many cases, but not always,
seen in close proximity to fissures (Fig. 2c, e) or in areas
where decreased matrix was seen.
The morphology of the nerves varied, depending on the
orientation of the nerves in the section. For example, in
Fig. 2a and b, nerve fibres and processes are visible,
whereas in Fig. 2f a cross-section of tissue reveals a bundle
of nerves stained with PGP9.5. Immunopositivity for
PGP9.5 varied throughout the sample cohort. A finding of
particular interest was the immunopositivity of NP cells
themselves in a large group of herniated tissue (Fig. 2g, h).
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Table 1 Patient details of human IVD samples
Reference ID Source IVD level IVD intact? Histological grade Classification Nerves identified
in abnormal location
Blood vessels identified
in abnormal location
HD 31 PM (SHU) L3-L4 Yes 3.0 ND Yes No
HD 32 PM (SHU) L3-L4 Yes 4.5 D Yes No
HD 37 PM (SHU) L3-L4 Yes 3.0 ND Yes No
HD 38 PM (SHU) L4-L5 Yes 7.5 D Yes No
HD 39 PM (SHU) L5-S1 Yes 11.5 D Yes Yes
HD E13-00073 PM (UT) L4-L5 5 D Yes No
HD 506-290 PM (UT) L4-L5 9 D Yes No
HD 507-280 PM (UT) L4-L5 7 D Yes Yes
HD 506-272 PM (UT) L4-L5 10 D Yes No
HD 508-263 PM (UT) L4-L5 11 D Yes No
HD 507-234 PM (UT) L4-L5 6 D Yes No
HD 508-223 PM (UT) L4-L5 7 D No No
HD 506-219 PM (UT) L4-L5 7 D No No
HD 506-207 PM (UT) L4-L5 7 D Yes No
HD 506-191 PM (UT) L4-L5 11 D Yes No
HD 507-192 PM (UT) L4-L5 11 D Yes Yes
HD 506-179 PM (UT) L4-L5 11 D Yes Yes
HD 507-164 PM (UT) L4-L5 5 D No No
HD 506-145 PM (UT) L4-L5 7 D Yes No
HD 506-136 PM (UT) L4-L5 9 D Yes Yes
HD 506-134 PM (UT) L4-L5 11 D Yes Yes
HD 507-110 PM (UT) L4-L5 8 D Yes No
HD 507-069 PM (UT) L4-L5 11 D No No
HD 508-070 PM (UT) L4-L5 9 D No Yes
HD 507-066 PM (UT) L4-L5 12 D Yes No
HD 507-051 PM (UT) L4-L5 10 D Yes Yes
HD 507-001 PM (UT) L4-L5 6 D Yes No
HD 1 Surgical L4-L5 No 2.5 ND No No
HD 5 Surgical L5-S1 Yes 8.5 D No No
HD 19 Surgical L5-S1 No 9.0 D Yes No
HD 46 Surgical L5-S1 Yes 8.5 D Yes No
HD 53 Surgical L5-S1 No 7.0 D Yes Yes
HD 55 Surgical L5-S1 No 6.0 D Yes Yes
HD 58 Surgical L5-S1 No 8.0 D Yes No
HD 60 Surgical L5-S1 Yes 5.0 D Yes Yes
HD 66 Surgical L3-L4 Yes 9.0 D Yes No
HD 67 Surgical L4-L5 Yes 5.0 D No No
HD 68 Surgical L4-L5 Yes 9.0 D Yes Yes
HD 69 Surgical L5-S1 No 8.5 D Yes No
HD 70 Surgical L5-S1 Yes 7.5 D No Yes
HD 71 Surgical L5-S1 Yes 6.5 D Yes No
HD 72 Surgical C5-C6 Yes 9.5 D Yes No
HD 74 Surgical L4-L5 No 7.5 D No No
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In some cases, nerves were found next to blood vessels
within the IAF (Fig. 2e) and also in close proximity to in-
filtrating cells in herniated samples, which are thought to
be immune in origin. Blood vessels were identified on ser-
ial haematoxylin and eosin–stained sections and further
confirmed by immunohistochemistry with detection of
Table 1 Patient details of human IVD samples (Continued)
HD 78 Surgical C3-C4 Yes 10.0 D Yes No
HD 84 Surgical C6-C7 Yes 5.0 D Yes No
HD 85 Surgical L2-L3 No 7.0 D Yes Yes
HD 88 Surgical 6.5 D Yes No
HD 89 Surgical L5-S1 No 4 ND Yes No
HD 90 Surgical 11.0 D Yes No
HD 91 Surgical 6 D Yes No
HD 92 Surgical L5-S1 3.5 ND Yes No
HD 93 Surgical L5-S1 7.0 D Yes No
HD 94 Surgical L5-S1 Yes 6.0 D Yes No
HD 95 Surgical L5-S1 Yes 6.0 D Yes Yes
HD 96 Surgical C5-C6 No 9.0 D Yes No
HD 98 Surgical L3-L4 Yes 6.0 D Yes No
HD 101 Surgical C6-C7 No 4.5 D Yes No
HD 104 Surgical L5-S1 No 5.5 D Yes No
HD 106 Surgical L4-L5 Yes 5.0 D Yes No
HD 110 Surgical L3 No 3.0 ND No No
HD 112 Surgical L5-S1 No 11.0 D No No
HD 124 Surgical L4-L5 No 3.5 ND No No
HD 127 Surgical L5-S1 No 4.0 ND Yes No
HD 146 Surgical L5-S1 5.85 D Yes No
HD 158 Surgical L4-L5 No 7.0 D Yes No
HD 159 Surgical L4-L5 No 3.0 ND Yes No
HD 161 Surgical C6-C7 Yes 7.0 D Yes No
HD 170 Surgical L5-S1 No 8.0 D Yes No
HD 174 Surgical L5-S1 Yes 7.0 D Yes No
HD 184 Surgical L4-L5 8.0 D Yes No
HD 207 Surgical L5-S1 No 7.0 D Yes No
HD 225 Surgical L5-S1 Yes 9.0 D No No
HD 226 Surgical L3-L4 No 5.5 D Yes Yes
HD 230 Surgical L5-S1 No 8.5 D Yes No
HD 231 Surgical L4-L5 No 5.0 D No NO
HD 233 Surgical L5-S1 Yes 9.5 D Yes No
HD 234 Surgical L5-S1 Yes 8.5 D Yes No
HD 243 Surgical L4-L5 Yes 6.0 D Yes Yes
HD 245 Surgical L4-L5 Yes 4.0 ND No No
HD 253 Surgical C5-C6 Yes 5.0 D Yes No
HD 263 Surgical 9.0 D No Yes
HD 272 Surgical L5-S1 No 4.5 D Yes No
HD 276 Surgical C5-C6 6.0 D No No
PM post-mortem, IVD intervertebral disc, SHU were processed at Sheffield Hallam University, UT were processed in Utrecht, L lumbar, C cervical, ND
non-degenerate, D degenerate
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CD31 (Fig. 2j–l). On the basis of this investigation, NF200
was taken forward as a marker of choice for the identifica-
tion of nerves due to the specificity within the NP tissue.
Tissues investigated for the presence of nerves (NF200)
and blood vessels (CD31) were separated on the basis of
grade of degeneration and whether they were positive or
negative for nerves and/or blood vessels (Table 1, Fig. 3).
Analysis revealed that 15 % of all samples were degenerate
and negative for nerves and blood vessels (NF200−/CD31
−), whilst 16 % of all samples were degenerate with nerves
and blood vessels (NF200+/CD31+) (Fig. 3a). In the
largest cohort, we identified 52 % of samples that were
degenerate with nerves but no blood vessels (NF200
+/CD31−) (Fig. 3a). Interestingly, only 4 % of all samples
were degenerate with no nerves but positive for blood
vessels (NF200−/CD31+) (Fig. 3a). Of the 85 samples in-
vestigated, only 6 % were non-degenerate without nerves
and blood vessels (NF200−/CD31−) and 7 % of non-
degenerate discs had nerves but no blood vessels (NF200
+/CD31−) (Fig. 3a). No samples were identified as being
non-degenerate with nerves but no blood vessels (NF200
+/CD31−) or non-degenerate with no nerves and positive
for blood vessels (NF200−/CD31+) (Fig. 3a). No differ-
ences were seen in the proportions of each group between
PM and surgical samples (Fig. 3b). Statistical analysis
revealed a significant difference in the number of tissue
samples displaying nerves and blood vessels between de-
generate and non-degenerate cohorts (p < 0.0001) (Fig. 3b).
Proportionality tests were performed to detect any signifi-
cant differences between the proportion of samples with
nerves and blood vessels. The proportion of degenerate
samples with nerves was significantly higher than the
proportion of non-degenerate samples with nerves present
(p = 0.0430). The proportion of degenerate samples ex-
pressing CD31 was significantly higher than within the
non-degenerate cohort (p = 0.0378). Non-degenerate and
degenerate samples demonstrated significantly higher pro-
portions of samples expressing nerves as opposed to blood
vessels (p = 0.0156 and p < 0.0001, respectively) (Fig. 3b).
Discussion
This study addresses the controversial topic of nerve
and blood vessel ingrowth into the IVD in a large num-
ber of patient samples obtained from surgery and PM.
The data presented show that nerves are present within
the IAF and NP of degenerate IVDs from patients with
histological evidence of disc degeneration, which con-
firms results shown in previous studies [21, 22, 27–30].
Studies by Freemont et al. demonstrated a link between
nerve ingrowth and painful discs in a cohort of 80
patient samples [21]. Their study and a similar study by
Brown et al. demonstrated that ingrowing nerves synthe-
sised small reactive substances involved in nociception,
such as substance P and CGRP [29], which could sensi-
tise nerves to painful stimuli. Freemont et al. furthered
their investigation by demonstrating that nerves entering
through the vertebral endplates were co-localised to nerve
growth factor (NGF)–expressing blood vessels [28], form-
ing the hypothesis that endothelial cells enter the IVD
first, followed by NGF receptor–expressing nerves which
track alongside the endothelial cells. Coppes et al. also
Table 2 Antibodies used for immunohistochemistry
Target antibody Clonality Optimal dilution Antigen retrieval method Secondary antibody Serum block
NF200 (ab82259) Mouse monoclonal 1:400 Heat Rabbit anti-mouse Rabbit
PGP9.5 (ab8189) Mouse monoclonal 1:200 Heat Rabbit anti-mouse Rabbit
CD31 (ab28364) Rabbit polyclonal 1:400 Enzyme Goat anti-rabbit Goat
CD31 cluster of differentiation factor 31, NF200 neurofilament 200, PGP protein gene product
Fig. 1 Rat spinal cord optimisation of neurofilament 200 (NF200) and protein gene product 9.5 (PGP9.5) staining at different sectioning thicknesses
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identified substance P–expressing nerve fibres extending
into the IAF of surgically removed IVD tissue [30].
More recent studies have shown that NP cells are able
to produce sensory peptides. Substance P and CGRP
and their regulation can be upregulated upon cytokine
stimulation [13]. Hence, if there is an increase in the
production of factors involved in sensitisation of nerve
endings, mechanical stimuli which are usually innocuous
to the disc nociceptors could in some cases cause ampli-
fied pain sensation.
Fig. 2 Expression of neurofilament 200 (NF200), protein gene product 9.5 (PGP9.5; (nerve) and cluster of differentiation factor 31 (CD31;
endothelial) immunopositive tissues within human intervertebral disc (IVD) samples. NF200-positive tissue demonstrates strong staining of the
axon and dendrites (a and b). Nerves were seen tracking along fissures (c). PGP9.5 staining revealed neuronal staining following the tracks of the
matrix in the nucleus pulposus (NP) (d), surrounding what appear to be blood vessels (e–i) and nerve bundles within the cartilaginous endplate
(CEP) (f). Cells within the NP (g) and annulus fibrosus (AF) (h) were positive for PGP9.5. Blood vessels were evident along the transition zone
between AF and NP (j), the outer annulus fibrosus (k) and also within regions above the CEP (l)
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A possible initiating factor of IVD degeneration is the
disruption of the vertebral endplate. Ohtori et al. observed
strong correlations between modic changes and innerv-
ation within the endplate and demonstrated links between
increased tumour necrosis factor (TNF)-α production and
nerve ingrowth [27]. Endplate disruption is also thought
to result in increased catabolic enzyme production, which
can degrade matrix molecules such as aggrecan. Aggrecan
derived from human IVDs is known for its ability to
inhibit neurite outgrowth and endothelial cell invasion
[17, 18]. Catabolic effects on the IVD, in particular the loss
of proteoglycans, has been suggested to be mediated by
growth factors and cytokines, in particular interleukin
(IL)-1β and TNF-α. Le Maitre et al. identified increased
expression of matrix metalloproteinase (MMP)-1, MMP-3
and MMP-13, as well as a disintegrin and metalloprotein-
ase with thrombospondin motifs 4 (ADAMTS4), from
human NP cells in degenerate samples compared with
non-degenerate samples [31]. Following from this, later
studies by the same group demonstrated regulation of
MMP-3, MMP-13 and ADAMTS4 by IL-1β in human NP
cells [25, 32, 33]. The loss of proteoglycans via the upregu-
lation of such aggrecanases from human NP cells could
permit the entry of stray nerves and blood vessels.
Aggrecan is also extensively known for its effect on disc
hydration by imbibing water; therefore, the cleavage of
aggrecan in degeneration can lead to loss of disc height
and pressure alterations within the NP, which can lead to
the extensive fissuring seen in degenerate IVDs [22].
Nerves found within IVDs investigated in the present
study are predominantly found close to fissures which
may provide a route into the inner areas of the IVD where
the fibrous matrix is disrupted. This is in agreement with
studies by Stefanakis et al., who reported strong localisa-
tion of nerve and blood vessels to annular fissures due to
its conducive environment to nerves and blood vessels
[22], hence providing a likely route into the deeper layers
of the IVD. Brown et al. also demonstrated that in severely
degenerate IVDs, where disc height is largely compro-
mised, there is an increase in the amount of blood vessels
present around the endplate [29], which ties in with the
loss of proteoglycans and water.
Unlike other researchers who have found strong co-
localisation of nerves with blood vessels [28, 29, 34, 35],
we observed nerve association with blood vessels on
only a few occasions. Subsequent analysis of the IVD tis-
sues revealed no samples which were histologically
graded as non-degenerate that had blood vessels and no
Fig. 3 Immunopositivity of neurofilament 200 (NF200) and cluster of differentiation factor 31 (CD31) in human intervertebral disc (IVD) tissues.
a Overall percentage of human IVD tissues where nerves and blood vessels were present or absent. b Number of tissues immunopositive for
NF200 and/or CD31 in the non-degenerate and degenerate cohorts within post-mortem (PM) and surgical samples
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nerves. The current hypothesis that surrounds nerve and
blood vessel ingrowth into the IVD is based upon NGF-
expressing endothelial cells entering the IVD first,
followed by sensory nerve fibres tracking alongside. In
this study, we did not find this to be the case; we ob-
served the presence of nerves without blood vessels
within both surgical and PM samples. Both surgical and
PM samples followed similar trends in terms of the pro-
portions of samples expressing nerve and blood vessels,
thus suggesting there is no difference between process-
ing techniques or section thickness. Filamentous staining
was observed more often in the surgical samples than in
the PM samples, which is thought to be due to the
thicker sections used in these samples. However, it has
to be taken into account that we looked at one section
of the sample and therefore cannot conclude that the
sample does not have nerves and/or blood vessels in
subsequent sections. Ideally, the whole tissue sample
would have been sectioned serially, allowing observation
of the whole specimen rather than one section. Due to the
nature of the tissue received from surgery, it is difficult to
determine where the nerves and blood vessels are derived
from, whether it is through the endplate or the AF.
Many studies have used PGP9.5 as a marker of choice
for the identification of nerves within IVD tissue [16, 20,
27, 34, 36–38]. However, in the present study, NP cell
immunopositivity was observed in many tissues. This is
interesting because no other studies have demonstrated
NP cells being immunopositive for this neural marker.
Studies using polymerase chain reactions to identify
PGP9.5 in cells isolated from human NP are quite
contradictory. Lee et al. demonstrated a strong positive
correlation with expression levels of PGP9.5 and NGF
within NP cells [16], whereas Tolofari et al. observed no
expression of PGP9.5 within human NP cells from vary-
ing grades of degeneration [20]. In studies using immu-
nohistochemistry to identify nerve fibres within the IVD,
researchers described their staining as specific to nerve
fibres and did not mention any PGP9.5-immunopositive
NP cells [16, 20, 27, 29, 35, 39], although no images con-
taining NP cells were published in their reports.
Conclusions
This study demonstrates a possible link between nerve in-
growth and degeneration of the IVD. It importantly iden-
tifies potential nerve ingrowth in the absence of blood
vessels, suggesting that nerves do not follow blood vessels
as previously suggested. However, further research should
be carried out to investigate the direction of ingrowth.
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